Company Overview of Dermira Inc.
Dermira Inc., a development-stage biotech company, focuses on developing and commercializing therapies in dermatology. The company’s portfolio of dermatology therapeutics includes lemuteporfin, a potent and selective topical photodynamic therapy for sebaceous gland disorders, including acne; DRM01, a topical sebum inhibitor targeting acne and sebaceous gland hyperactivity; and DRM02, a topical kinase inhibitor targeting inflammatory skin diseases. The company was founded in 2010 and is based in Redwood City, California. It has operations in Vancouver, Canada.
2055 Woodside Road
Redwood City, CA 94061
Founded in 2010
Key Executives for Dermira Inc.
Similar Private Companies By Industry
|Algorithme Pharma USA Inc.||United States|
|Matrivax Research & Development Corp.||United States|
|Phyton Biotech, Inc.||United States|
|BioSurface Technologies Corporation||United States|
|Collaborative Neuroscience Network, Inc.||United States|
Recent Private Companies Transactions
|No transactions available in the past 12 months.|
Most Searched Private Companies
|Company Name||Geographic Region|
|NYC2012, Inc.||United States|
|Lawyers Committee for Civil Rights Under Law||United States|
|Rush University||United States|
|Greater Houston Partnership||United States|
Post a JobJobs
- Boston, MA | PwCPosted: Aug 28
- Madison, WI | Madison Area Technical CollegePosted: May 23
- Kennebunk, ME | CorningPosted: May 24
- San Francisco, CA | Confidential Biotechnology CompanyPosted: May 13
Sponsored Financial Commentaries
To contact Dermira Inc., please visit www.dermira.com. Company data is provided by Capital IQ. Please use this form to report any data issues.